Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.50
03.05.21
€8.00
03.05.22
2.31%
17.05.21

Could be worthwhile Investment >10% per year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.72
03.05.21
€5.00
03.05.22
-5.88%
17.05.21

Could be worthwhile Investment >10% per year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€4.72
03.05.21
€6.00
03.05.22
-5.93%
17.05.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€7.90
03.05.21
€10.00
03.05.22
-15.32%
17.05.21

Could be very worthwhile Investment >20% year
buy
American Tower Corp.

Start price
Target price
Perf. (%)
€212.20
02.05.21
€218.00
02.05.22
6.88%
03.05.22

Could be worthwhile Investment >10% per year
buy
Altria Group Inc.

Start price
Target price
Perf. (%)
€39.70
02.05.21
-
02.05.22
33.27%
03.05.22

Could be worthwhile Investment >10% per year
Tesla Inc

Start price
Target price
Perf. (%)
€195.00
02.05.21
€160.00
02.05.22
63.44%
06.01.22

Tesla Inc

Start price
Target price
Perf. (%)
€195.00
02.05.21
€160.00
02.05.22
63.44%
06.01.22

Meta Platforms Inc.

Start price
Target price
Perf. (%)
€270.55
02.05.21
€250.00
02.12.21
2.57%
02.12.21

High dividend yield expected
Probably not worthwhile Investment
High valuation
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€270.55
02.05.21
€250.00
02.12.21
2.57%
02.12.21

High dividend yield expected
Probably not worthwhile Investment
High valuation
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€270.55
02.05.21
€250.00
02.12.21
2.57%
02.12.21

High dividend yield expected
Probably not worthwhile Investment
High valuation
buy
Stericycle Inc.

Start price
Target price
Perf. (%)
€63.74
02.05.21
€66.00
02.05.22
-24.93%
02.05.22

Could be worthwhile Investment >10% per year
buy
Stericycle Inc.

Start price
Target price
Perf. (%)
€63.74
02.05.21
€66.00
02.05.22
-24.93%
02.05.22

Could be worthwhile Investment >10% per year
buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€461.10
02.05.21
€465.00
02.05.22
25.33%
02.05.22

Could be worthwhile Investment >10% per year
buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€461.10
02.05.21
€465.00
02.05.22
25.33%
02.05.22

Could be worthwhile Investment >10% per year
buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€461.10
02.05.21
€465.00
02.05.22
25.33%
02.05.22

Could be worthwhile Investment >10% per year
buy
Willis Towers Watson plc

Start price
Target price
Perf. (%)
€218.00
02.05.21
€210.00
02.05.22
-6.42%
02.05.22

Could be worthwhile Investment >10% per year
buy
Willis Towers Watson plc

Start price
Target price
Perf. (%)
€218.00
02.05.21
€210.00
02.05.22
-6.42%
02.05.22

Could be worthwhile Investment >10% per year
buy
Nathan S Famous

Start price
Target price
Perf. (%)
€52.00
01.05.21
€70.00
01.05.22
-15.00%
02.05.22

Could be worthwhile Investment >10% per year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€370.00
01.05.21
-
01.05.22
-5.65%
02.09.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
buy
Centene Corp.

Start price
Target price
Perf. (%)
€51.00
01.05.21
€56.00
01.05.22
50.31%
02.05.22

Could be worthwhile Investment >10% per year
buy
Pra Group Inc

Start price
Target price
Perf. (%)
€31.20
01.05.21
€33.00
01.05.22
27.56%
02.05.22

Could be worthwhile Investment >10% per year
buy
Wingstop Inc

Start price
Target price
Perf. (%)
€131.00
01.05.21
€132.00
01.05.22
-33.97%
02.05.22

Could be worthwhile Investment >10% per year
buy
Alphabet Inc. C

Start price
Target price
Perf. (%)
€100.68
01.05.21
€125.00
01.05.22
9.26%
01.05.22

buy
Autozone Inc.

Start price
Target price
Perf. (%)
€1,218.0
30.04.21
-
30.04.22
24.38%
18.10.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Very low/no dividend yield expected